Senior insider sale
EVP and CFO at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$3.16M
7K shares
What this filing means
WAGNER CHARLES F JR plans to sell 7K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $3.16M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/3/2025ACC: 0001959173-25-007468
Officer· EVP and CFO
Since Apr 2019
7K
Shares to sell
$3.16M
Approx. market value
7K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Restricted Stock Vesting
Compensation
2/24/2024
3.53KRestricted Stock Vesting
Compensation
2/17/2024
3.47KTotal acquired7K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/24/2024 | Restricted Stock Vesting Compensation | 3.53K | — |
2/17/2024 | Restricted Stock Vesting Compensation | 3.47K | — |
| Total | 7K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
7K
Market value
$3.16M
12/3/2025
Total
Units
7K
Value
$3.16M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/3/2025 | 7K | $3.16M | NASDAQ | Planned |
| Total | 7K | $3.16M | ||